Found: 2

Select item for more details and to access through your institution.

  • The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study.

    Published in:
    CNS Drugs, 2022, v. 36, n. 11, p. 1207, doi. 10.1007/s40263-022-00956-8
    By:
    • Frank, Samuel;
    • Testa, Claudia;
    • Edmondson, Mary C.;
    • Goldstein, Jody;
    • Kayson, Elise;
    • Leavitt, Blair R.;
    • Oakes, David;
    • O'Neill, Christine;
    • Vaughan, Christina;
    • Whaley, Jacquelyn;
    • Gross, Nicholas;
    • Gordon, Mark Forrest;
    • Savola, Juha-Matti;
    • The Huntington Study Group/ARC-HD Investigators and Coordinators;
    • Stamler, David;
    • Bockus, Margaret;
    • Leyva, Stephanie;
    • Snively, Victoria;
    • Wong, Cynthia;
    • Mallonee, William M.
    Publication type:
    Article

  • Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.

    Published in:
    2016
    By:
    • Frank, Samuel;
    • Huntington Study Group;
    • Testa, Claudia M;
    • Stamler, David;
    • Kayson, Elise;
    • Davis, Charles;
    • Edmondson, Mary C;
    • Kinel, Shari;
    • Leavitt, Blair;
    • Oakes, David;
    • O'Neill, Christine;
    • Vaughan, Christina;
    • Goldstein, Jody;
    • Herzog, Margaret;
    • Snively, Victoria;
    • Whaley, Jacquelyn;
    • Wong, Cynthia;
    • Suter, Greg;
    • Jankovic, Joseph;
    • Jimenez-Shahed, Joohi
    Publication type:
    journal article